Fanny Erika Palumbo
9PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.Salvatore Perrone, Andrea Corbingi, Calogero Vetro
|Jan 28, 2026
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders.Andrea Duminuco, Paola De Luca, Gaia Stanzione
|Jan 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort.Calogero Vetro, Irene Azzali, Elisabetta Petracci
|Dec 31, 2025
Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database.Arianna Scala, Teresa Angela Trunfio, Chiara Pennisi
|Oct 28, 2025
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database.Pier Paolo Olimpieri, Fanny Erika Palumbo, Gaetano Giuffrida
|Aug 14, 2025
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study.Ermelinda Longo, Fanny Erika Palumbo, Andrea Duminuco
Pageof 2
Frequent Collaborators
9 joint publications
Calogero Vetro
4 joint publications
Lucia Gozzo
3 joint publications
Andrea Duminuco
3 joint publications
Giovanni Marconi
3 joint publications
Giuseppe Alberto Palumbo
3 joint publications
Giovanni Luca Romano
3 joint publications
Salvatore Perrone
3 joint publications
Fabio Guolo
2 joint publications
Francesco Grimaldi
2 joint publications
Raffaele Palmieri
